Buprenorphine versus methadone maintenance treatment in an ambulant setting: a health‐related quality of life assessment

Giacomuzzi, Salvatore; Riemer, Y.; Ertl, M.; Kemmler, Georg; Rössler, H.; Hinterhuber, Hartmann; Kurz, Megan

doi:10.1046/j.1360-0443.2003.00352.x

Cited by 96 publications

(69 citation statements)

References 57 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, there are very few studies documented in the literature that have investigated this assumption. For nonclinical populations we could not find research done and studies that have an element of quality of life measurement are restricted to opiate users receiving treatment from various agencies [1,2,3,4,5,6,7].…”

Section: Introductionmentioning

confidence: 99%

Psychoactive Drugs and Quality of Life

Ventegodt

Merrick

2003

The Scientific World JOURNAL

View full text Add to dashboard Cite

Our study showed that over half the Danish population had used illegal psychotropic drugs. The most commonly used was cannabis (marijuana) though experience of this drug appeared not to co-vary with QOL to any significant extent. Cocaine, amphetamine, and psilocybin had been used by 1.2 to 3.3% of the population and this varied with QOL to a clear albeit small extent. LSD has been used by 1.2% of the population and the users had a QOL score 10% lower than those who had never used psychotropic drugs. The group with the lowest quality of life was found to be persons who had used heroin, morphine, methadone, and a mixture of alcohol and tranquilizers (10-20% below the group with the highest quality of life).

show abstract

Section: Introductionmentioning

confidence: 99%

Psychoactive Drugs and Quality of Life

Ventegodt

Merrick

2003

The Scientific World JOURNAL

View full text Add to dashboard Cite

show abstract

“…Various professions create their own interpretations, with little resemblance and much fragmentation in-between disciplines (Farquhar 1995;Rapley 2003). Nonetheless, there is a growing recognition of QoL as an important indicator for the impact of treatment, the need for health care, the evaluation of interventions and for cost-benefit analyses (Allison et al 1997;Carr and Higginson 2001;Foster et al 2000;Giacomuzzi et al 2003;Oliver et al 1997;Torrens et al 1997).…”

Section: The Concept Of Qolmentioning

confidence: 99%

Exploratory Study on Drug Users’ Perspectives on Quality of Life: More than Health-Related Quality of Life?

2008

View full text Add to dashboard Cite

In drug treatment outcome literature, a focus on objective and socially desirable indicators of change (e.g. no drug use) has predominated, while outcome indicators that are important for drug users themselves (e.g. quality of life, satisfaction with treatment) have largely been neglected. Nonetheless, Quality of Life (QoL) has become an important concept to evaluate effectiveness of treatment in mental health care research and disability studies. Given the almost exclusive focus on Health-related Quality of Life (HRQOL) in substance abuse research and the neglect of clients' perspectives in this field, we explore in this study the concept of QoL as perceived by drug users. Focus group discussions (n = 9) were organised in various treatment settings and community services for drug users in the region of Ghent, Belgium to identify important dimensions of QoL and their interpretation by drug users. Data were clustered and analysed based on the theoretical framework of Robert Schalock (Quality of life. Volume 1: Conceptualization and measurement, 1996). The domains 'personal relationships', 'social inclusion' and 'self-determination' were discussed most frequently by the participants. They stressed the importance of a supportive social network in particular. It can be concluded that QoL is not primarily associated by drug users with health and it involves much more than the aspects typically represented in measures of HRQOL.

show abstract

“…La buprénorphine à haut dosage est apparue sur le marché vers le milieu des années 1990 et constitue une autre approche pharmacologique dont l'efficacité est comparable à celle de la méthadone (Kakko & al., 2007 ;Giacomuzzi & al., 2003 ;Mattick & al., 2003 ;Schottenfeld & al., 2005). La réten-tion est cependant légèrement supérieure avec la méthadone.…”

Section: Palabras Clave: Metadona Buprenorfina Dependencia a Los Opunclassified

Les effets indésirables des médicaments de substitution dans le traitement de la dépendance aux opioïdes

Lauzon

2012

dss

View full text Add to dashboard Cite

Le traitement de substitution, principalement avec la méthadone ou la buprénorphine, représente le traitement le plus efficace de la dépendance des opioïdes. Ces médicaments doivent, la plupart du temps, être pris pendant des périodes prolongées, soit plusieurs années ou toute la vie pour certains. Ces médicaments peuvent avoir des effets indésirables, ayant un impact sur la qualité de vie des patients, et nécessitent une attention de la part des professionnels de la santé impliqués dans le traitement. Seront révisés les effets indésirables suivants : hypogonadisme masculin, allongement du QT, sevrage néonatal, anomalies des fonctions respiratoires, hyperalgésie, risque d’intoxication, abus de la médication, interactions médicamenteuses. À ces effets pharmacologiques viennent s’ajouter des contraintes réglementaires, qui, si elles peuvent être pertinentes en début de traitement, s’avèrent lourdes et inadaptées pour les patients stables depuis plusieurs années. De l’écoute et une bonne gestion de ces effets indésirables sont indispensables pour améliorer l’acceptabilité du traitement et son attrait pour les usagers.

show abstract

Buprenorphine versus methadone maintenance treatment in an ambulant setting: a health‐related quality of life assessment

Cited by 96 publications

References 57 publications

Psychoactive Drugs and Quality of Life

Psychoactive Drugs and Quality of Life

Exploratory Study on Drug Users’ Perspectives on Quality of Life: More than Health-Related Quality of Life?

Les effets indésirables des médicaments de substitution dans le traitement de la dépendance aux opioïdes

Contact Info

Product

Resources

About